Search hospitals > New York > New York

Mount Sinai Hospital

Claim this profile
New York, New York 10029
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Stroke
Conducts research for Lung Cancer
Conducts research for Breast cancer
681 reported clinical trials
132 medical researchers
Photo of Mount Sinai Hospital in New YorkPhoto of Mount Sinai Hospital in New YorkPhoto of Mount Sinai Hospital in New York

Summary

Mount Sinai Hospital is a medical facility located in New York, New York. This center is recognized for care of Cancer, Breast Cancer, Stroke, Lung Cancer, Breast cancer and other specialties. Mount Sinai Hospital is involved with conducting 681 clinical trials across 1,048 conditions. There are 132 research doctors associated with this hospital, such as Pillai Pallavi Madhusoodhan, Gary D. Crouch, Deborah Doroshow, MD, PhD, and Matthew Galsky, M.D..

Area of expertise

1Cancer
Global Leader
Mount Sinai Hospital has run 45 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage III
2Breast Cancer
Global Leader
Mount Sinai Hospital has run 35 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Mount Sinai Hospital

Breast Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Colorectal Cancer
Testicular cancer
Atrial Fibrillation
Prostate Cancer
Breast cancer
Stroke
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mount Sinai Hospital?
Where is Mount Sinai Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mount Sinai Hospital accept?
What awards or recognition has Mount Sinai Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security